share_log

Tharimmune Forms Scientific Advisory Board To Drive Clinical-Stage Lead In Chronic Liver Disease And Early-Stage Tunable Knob Domains For Generating Antibody Drug Conjugate Biotherapeutics

Moomoo 24/7 ·  Apr 15 08:35

Group includes leading experts in multiple disciplines including immunology, liver diseases, protein engineering, antibody drug conjugates and platform innovation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment